HealthSouth Corp. (NYSE:HLS) shares gapped up before the market opened on Thursday . The stock had previously closed at $38.22, but opened at $38.38. HealthSouth Corp. shares last traded at $39.23, with a volume of 263,366 shares changing hands.

A number of research analysts recently issued reports on the company. Robert W. Baird restated a “buy” rating on shares of HealthSouth Corp. in a research report on Monday, May 16th. Zacks Investment Research upgraded HealthSouth Corp. from a “sell” rating to a “hold” rating in a research report on Tuesday, March 15th. Barclays PLC boosted their price objective on HealthSouth Corp. from $39.00 to $45.00 and gave the company an “equal weight” rating in a research report on Thursday, April 28th. Finally, Mizuho boosted their price objective on HealthSouth Corp. from $40.00 to $47.00 and gave the company a “buy” rating in a research report on Friday, April 29th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the stock. HealthSouth Corp. presently has a consensus rating of “Buy” and a consensus target price of $45.00.

The stock has a market cap of $3.58 billion and a P/E ratio of 19.20. The company has a 50 day moving average price of $39.96 and a 200-day moving average price of $37.03.

HealthSouth Corp. (NYSE:HLS) last released its quarterly earnings results on Tuesday, April 26th. The company reported $0.61 EPS for the quarter, topping the Zacks’ consensus estimate of $0.55 by $0.06. The business had revenue of $909.80 million for the quarter, compared to the consensus estimate of $892.87 million. During the same quarter last year, the company earned $0.51 earnings per share. The firm’s revenue was up 22.8% on a year-over-year basis. On average, analysts forecast that HealthSouth Corp. will post $2.46 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 15th. Investors of record on Friday, July 1st will be given a dividend of $0.23 per share. The ex-dividend date is Wednesday, June 29th. This represents a $0.92 dividend on an annualized basis and a yield of 2.32%.

In related news, insider Cheryl B. Levy sold 11,000 shares of the stock in a transaction that occurred on Friday, April 29th. The stock was sold at an average price of $41.44, for a total transaction of $455,840.00. Following the sale, the insider now directly owns 97,513 shares in the company, valued at approximately $4,040,938.72. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

A number of large investors have added to or reduced their stakes in HLS. Victory Capital Management Inc. raised its stake in HealthSouth Corp. by 1.3% in the fourth quarter. Victory Capital Management Inc. now owns 3,599,346 shares of the company’s stock worth $125,294,000 after buying an additional 45,264 shares during the period. Bank of Montreal Can raised its stake in HealthSouth Corp. by 6.1% in the fourth quarter. Bank of Montreal Can now owns 755,841 shares of the company’s stock worth $26,312,000 after buying an additional 43,407 shares during the period. Dimensional Fund Advisors LP raised its stake in HealthSouth Corp. by 28.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 664,123 shares of the company’s stock worth $23,119,000 after buying an additional 148,065 shares during the period. Principal Financial Group Inc. raised its stake in HealthSouth Corp. by 0.4% in the fourth quarter. Principal Financial Group Inc. now owns 613,748 shares of the company’s stock worth $21,365,000 after buying an additional 2,172 shares during the period. Finally, Wells Fargo & Company MN raised its stake in HealthSouth Corp. by 11.3% in the fourth quarter. Wells Fargo & Company MN now owns 606,840 shares of the company’s stock worth $21,124,000 after buying an additional 61,740 shares during the period.

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.